Synthesis of a selective HDAC6 inhibitor active in neuroblasts
- 1 October 2016
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 26 (20) , 4955-4959
Abstract
No abstract availableKeywords
Funding Information
- Centre National de la Recherche Scientifique
- University of Poitiers
- Region Poitou-Charentes (FEB grant)
- Ligue Contre le Cancer
- Vendée, et Charente-Maritime
- COST Actions (CM1106, CM1406)
- Excellence programme of the University of Geneva
- Swiss National Science Foundation (P300P3_158507)
This publication has 30 references indexed in Scilit:
- Class I HDACs Share a Common Mechanism of Regulation by Inositol PhosphatesMolecular Cell, 2013
- pH-gradient PAMPA-based in vitro model assay for drug-induced phospholipidosis in early stage of drug discoveryEuropean Journal of Pharmaceutical Sciences, 2013
- SIRT1 and SIRT2: emerging targets in neurodegenerationEMBO Molecular Medicine, 2013
- HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs?Molecular Neurodegeneration, 2013
- Reducing HDAC6 ameliorates cognitive deficits in a mouse model for Alzheimer's diseaseEMBO Molecular Medicine, 2012
- Rational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin AJournal of the American Chemical Society, 2010
- HDAC6 Regulates Mitochondrial Transport in Hippocampal NeuronsPLOS ONE, 2010
- Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike PropertiesACS Chemical Neuroscience, 2010
- Inhibitors of Class 1 Histone Deacetylases Reverse Contextual Memory Deficits in a Mouse Model of Alzheimer's DiseaseNeuropsychopharmacology, 2009
- Chronic, low-dose rotenone reproduces Lewy neurites found in early stages of Parkinson's disease, reduces mitochondrial movement and slowly kills differentiated SH-SY5Y neural cellsMolecular Neurodegeneration, 2008